Cell and gene therapies are exciting new modalities that have the potential to treat, and even cure, a range of diseases that may not be possible with small molecules or monoclonal antibodies. However ...
Real-world adherence and tolerability of FLT3 inhibitors as post-allogeneic transplant maintenance therapy in older adults with AML: A Medicare claims data cohort study. This is an ASCO Meeting ...
RADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results